Fundraising Fox
Fresenius Medical Care Ventures
Corporate VCBad Homburg · Seed–Late Stage · 8 people tracked
Find your way into Fresenius Medical Care Ventures
1,770 people in our graph share verified history with the Fresenius Medical Care Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
FMCV pursues strategic corporate venture investments aligned with Fresenius Medical Care's priorities, aiming to bring innovation to patients. It invests in start-ups and early-stage companies across multiple healthcare sectors, including medical devices, pharmaceuticals, digital healthcare, and healthcare services. Beyond capital, it forms collaborative partnerships and leverages the parent company's resources to help portfolio companies navigate the path of bringing innovation to patients. FMCV invests from seed stage through later stages depending on how companies fit its corporate objectives, and takes an active role including board participation and value-creation support.
Source: firm website, verified Sep 27, 2026.
Team · 8 people
from the firm's website & public directories
What they invest in
from 18 of 24 portfolio companiesHealthtech ×14Medical Devices ×13Biotech ×8Digital Health ×8Hardware ×4Deep Tech ×2AI & Machine Learning ×1IoT ×1
HQs:United States×11Canada×1Switzerland×1Germany×1Israel×1
Investments · 24 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12021 · 12019 · 12018 · 15 dated
DocGo provides mobile and virtual health services, including medical transportation for hospitals, care gap closure and longitudinal care programs for payers, and population health programs for public health departments.
Digital HealthHealthtechNew York, US
Lee Bienstock(Chief Executive Officer)inNorm Rosenberg(Treasurer and Chief Financial Officer)inStephen Sugrue(Chief Compliance Officer)inBonu Kapoor(Chief Medical Officer of SteadyMD; VP of Clinical Practice & Innovation at DocGo)inHawk Newton(Chief Technology Officer)inEly D. Tendler(General Counsel)
Co-investorsAlpha Ascent Ventures LlcValor Equity Partners
Humacyte is a regenerative medicine company that develops a bioengineered, human-derived Acellular Tissue Engineered Vessel (ATEV) along with a scalable cell sourcing and manufacturing platform.
BiotechHealthtechMedical DevicesMorrisville, US
Laura E. Niklason(Director)inLaura Niklason, MD, PhD(Founder)inTed Lithgow(Executive Officer)inPaul Boyer(Executive Officer)inCarrie S. Cox(Executive Officer, Director)Dale A. Sander(Chief Financial Officer, Chief Corporate Development Officer and Treasurer)in
Co-investorsFirst In VenturesOberland Capital
Retia Medical develops advanced hemodynamic monitoring devices, including the Argos Cardiac Output Monitor, which uses proprietary algorithms to provide real-time clinical decision support for high-risk patients.
AI & Machine LearningDigital HealthHealthtechMedical Devices
Marc Zemel(Co-Founder and CEO)inRamakrishna Mukkamala(Co-Founder)inJerry Korten(Executive Vice President)inRoger Mecca(Consultative Medical Officer)inAlexander Markovic(Chief Operating Officer)in
Co-investorsRed Cedar
Albutec develops extracorporeal albumin dialysis (ECAD) technology, including its MaxiCycler device with redesigned adsorbent and tubing, to support or replace liver function in patients with acute and acute-on-chronic liver failure.
BiotechHardwareHealthtechMedical DevicesRostock, DE
Katrin Stange(Chief Executive Officer)inJan Stange(Chief Medical Officer)inDipl.-Med. Katrin Stange(Chief Executive Officer)
BioIntelliSense develops scalable physiologic monitoring technology for continuous, proactive patient monitoring aimed at improving clinical outcomes and lowering the cost of care.
Digital HealthHealthtechIoTMedical DevicesGolden, US
James Mault(Executive Officer, Director)inDavid Wang(Executive Officer, Director)inRonald Chwang(Director)Alan Meeker(Director)Larry Leisure(Director)Steve Hess(Director)
Co-investorsBose VenturesCU Healthcare Innovation FundSkyPoint Ventures
eGenesis uses gene editing and genome engineering to develop porcine donor animals for cross-species organ transplantation, addressing organ failure treatment and transplant supply constraints.
BiotechDeep TechMedical Devices
Mike Curtis, Ph.D.(President & Chief Executive Officer)
Co-investorsAlta PartnersAltium CapitalEisai Innovation, Inc.Khosla VenturesLux Capital
Biotechnology company using multiplex gene editing to develop genetically engineered porcine organs for human transplantation.
BiotechBrookline, US
Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)
BoardGeorge M. Church(Director)
Co-investorsAlta PartnersARCH Venture PartnersCatalio Capital Management, LPHBM Healthcare InvestmentsHBM PartnersKhosla Ventures+13 more
BiotechHealthtechMedical DevicesMartinez, US
Michael DiMeo(Executive Officer)inErin Borger(Executive Officer, Director)inRobert S. Ward(Executive Officer, Director)inKeith McCrea(Executive Officer, Director)inGeorge Pitarra(Executive Officer, Director)inKathleen White(Executive Officer)in
Co-investorsCycad Group LLC
MagentaMed develops the Elevate percutaneous Left Ventricular Assist Device (pLVAD), a low-profile, high-flow arterial pump for temporary mechanical circulatory support.
HardwareHealthtechMedical DevicesKadima, IL
Yosi Tuval(MSc – Co-Founder & CTO)Ehud Schwammenthal(MD, PhD – Co-Founder & CMO)inDavid Israeli(MD, MBA – Chairman & CEO)in
Co-investorsALIVE Israel HealthTech FundNew Enterprise Associates (NEA)OrbiMedRA CapitalPitango
Memo Therapeutics develops therapeutic antibodies targeting viral infections to improve treatment outcomes for patients with conditions like BKPyV infection in kidney transplant recipients and oncological viral diseases.
BiotechMedical DevicesZurich, CH
Co-investorsKurma PartnersPureos BioventuresYsios CapitalAdjuvant CapitalVerve Venturesredalpine
.jpeg){kind=logo}
Modulim develops microvascular imaging and data solutions that help clinicians assess and manage lower limb health in patients at risk of complications from diabetes, kidney disease, and peripheral arterial disease.
Digital HealthHealthtechMedical DevicesIrvine, US
David Cuccia(Executive Officer, Director)Richard Oberreiter(Executive Officer)Bruce Tromberg(Director)
BoardJoseph Rinehart(Director)Randall Lunn(Director)Andrew Campbell(Director)
Co-investorsCove FundMitsubishi UFJ Capital
Modulim develops spatial frequency domain imaging (SFDI) technology that provides clinicians with microvascular and tissue oxygenation insights for the lower limb, supporting assessment of conditions such as diabetic circulatory complications.
Digital HealthHealthtechMedical DevicesIrvine, US
David J. Cuccia(Founder & Chief Technology Officer)inCharlie Huiner(President & Chief Executive Officer)inAmaan Mazhar(Chief Product Officer)in
Co-investorsPangaea Ventures Us Inc.
SafeRide Health provides non-emergency medical transportation (NEMT) through a technology platform and a nationwide network of transport and rideshare providers, connecting patients — largely Medicare Advantage and Medicaid members — to healthcare appointments.
Digital HealthHealthtechMobility & Transportation
Robbins Schrader(Chief Executive Officer, Co-Founder)Ben Salter(Chief Product Officer, Co-Founder)inWhit Schrader(VP of Ops Transformation, Co-Founder)in
Co-investorsAmplify.LABonfire VenturesFCA Venture PartnersHatteras Venture PartnersHDS CapitalLayout Ventures+5 more
Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine.
BiotechDeep TechHealthtechMedical DevicesEdina, US
Jay Katarincic(Founder, Stimdia Medical; Director, Draper Triangle Ventures)inJim Bullock(Founder, Stimdia Medical; Board Chairman)Patrick Wethington(Executive Officer, Director)inAllen Meacham(President and Chief Executive Officer)inBrad Swatfager(Chief Financial Officer)Kristen Lechleiter(Vice President, Clinical and Regulatory Affairs)in
Co-investorsSolas BioVentures
Lucet (formerly Tridiuum) combines technology and clinical expertise to improve access to behavioral and mental health care, connecting people to appropriate providers and services.
Digital HealthHealthtechMental HealthPhiladelphia, US
Grant Grissom(Executive Officer, Director)Paul Castaldo(Mr. Castaldo is the Chief Operating Officer of the Issuer.)Mark A. Redlus(Executive Officer, Director)Martin Nankin(Executive Officer, Director)Mark Anthony(Executive Officer, Director)Edward Camarota(Executive Officer)in
Co-investorsBaleon CapitalMartinson Ventures
Vectorious Medical Technologies develops implantable sensing platforms designed to deliver clinical information for patient therapies.
Digital HealthHardwareHealthtechMedical Devices
Co-investorsBroadview VenturesChampel CapitalGEOC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlucentAlucent BiomedicalCorvidiaCorvidia TherapeuticsMagnetaModuliumVectorius
Exits · 3
2 IPOs · 1 acquisitionsDocgoNASDAQ: DCGOHumacyteNASDAQ: HUMAMemo Therapeutics AGacq. by Clementia
Frequently asked questions
- How many investments has Fresenius Medical Care Ventures made?
- Fresenius Medical Care Ventures has 24 tracked investments, 3 of which have exited.
- What stage does Fresenius Medical Care Ventures invest at?
- Fresenius Medical Care Ventures invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Fresenius Medical Care Ventures focus on?
- Fresenius Medical Care Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Fresenius Medical Care Ventures located?
- Fresenius Medical Care Ventures is headquartered in Bad Homburg, DE.
- Who does Fresenius Medical Care Ventures co-invest with?
- Fresenius Medical Care Ventures most often shares deals with New Enterprise Associates (NEA), Alpha Ascent Ventures Llc, Khosla Ventures, among 34 tracked co-investors.
Media · Podcasts & interviews
from their channelResearch in Brief: Online hemodiafiltration and medium cut-off dialyzers | FME
Fresenius Medical Care
Research in Brief: Personalizing meal planning for people with chronic kidney disease
Fresenius Medical Care
Research in Brief: Why lean tissue index matters in HDF | FME
Fresenius Medical Care
Research in Brief: Immunosuppressive therapies in kidney transplant recipients | FME
Fresenius Medical Care
Research in Brief: Population Characteristics in Randomized Trials for HDF | FME
Fresenius Medical Care
Artful Resilience: Samroeng Getlim's Story | Life on Dialysis – FME Asia Pacific
Fresenius Medical Care
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.